Specialty CRO for Complex Phase I–IV Trials

Complex programs need a specialty CRO expertise

Advance complex clinical programs with a CRO built to connect scientific strategy, clinical execution, biometrics, and regulatory expertise from early development through pivotal trials.

TALK TO AN EXPERT →
Complex Development Demands a Different Kind of CRO

Complex science, hard-to-reach patients, challenging endpoints, and evolving regulatory paths demand specialized expertise. Veristat brings clinical operations, biometrics, medical writing, and regulatory expertise together to support Phase I–IV development.

30+ years

sponsors have turned to us to navigate critical development decisions, execute complex studies, and build the evidence needed to move promising therapies toward patients.

Make Every Phase Build Toward What Comes Next

The strongest development programs connect decisions across the lifecycle. Protocol design affects feasibility, data strategy shapes analysis, and trial execution influences regulatory readiness.

Veristat brings these disciplines together around one development strategy, helping sponsors anticipate downstream requirements, address issues earlier, and build a more connected path through each phase.

Complex Programs Leave Less Room for the Wrong Decision

Every development decision carries weight. Difficult protocols, slow enrollment, unexpected data issues, or late regulatory requirements can have consequences beyond a single study.

For lean sponsor teams, experienced people who anticipate what comes next and understand how decisions across disciplines affect one another are especially critical for complex therapies, where established playbooks may not be enough.

One Development Partner Connected Around Your Program.

 

Veristat brings scientific strategy, clinical operations, biometrics, regulatory affairs, medical and safety expertise, and medical writing together under one partner.

Full-service capabilities include:

Our teams work across disciplines so study design reflects operational realities, statistical thinking informs decisions early, and evidence is developed with regulatory requirements and submission readiness in mind.

Strategic Consulting

Development strategy from IND/CTA planning through post-approval

Learn more →
Biometrics

Biostatistics, statistical programming, and clinical data management

Learn more →
Clinical Operations

Feasibility, site selection and management, recruitment and retention, monitoring, and project management

Learn more →
Quality Assurance

Quality expertise supporting compliant, inspection-ready clinical development

Learn more →
Regulatory Science

Regulatory and medical writing, submission leadership, disclosure and transparency, regulatory operations, safety, and document quality

Learn more →
Medical Affairs & Safety

Medical monitoring, pharmacovigilance, patient safety, and medical affairs support

Learn more →
Regulatory Affairs

Regulatory strategy, gap analysis, agency interactions, submissions, registration, and lifecycle support

Learn more →

What Do You Need From Your CRO Right Now?

The right CRO relationship looks different at each stage of development.

Our CRO Scorecard will help you identify the expertise, capabilities,
and questions that matter most for where your program is today, and what it needs to accomplish next.

Expertise That Changes How We Approach Your Program

A full-service CRO should bring more than functions and resources. It should bring experience that improves decisions throughout development.

Veristat teams work across clinical development and regulatory submission, bringing perspective on how today’s decisions affect what comes next. That experience is especially deep in oncology, rare diseases, neurology, cell and gene therapy, biologics, and other complex therapies where specialized expertise matters.

Experience behind your program: 

30+

years of clinical development experience

400+

projects supported annually

170+

marketing applications supported

105

approvals contributed to, including 70+ in rare diseases 


350+

rare and ultra-rare disease clinical trials and consulting projects

375+

biologics clinical trials and consulting projects 


100+

marketing applications supported

150+

INDs and 15+ CTAs prepared in the past five years

Global Reach. Regulatory Experience Where It Matters.

 

Complex development increasingly crosses borders, requiring both global reach and an understanding of local regulatory environments.

Veristat combines its North American foundation with operations across Europe and Asia, supporting global and regional development strategies through an integrated approach. Sponsors can account for global considerations earlier while working with teams experienced in the requirements of major regulatory authorities.

OUR EXPERTS
Experienced People at the Table

 

Complex programs benefit from experienced people who can see beyond their individual workstream. Veristat brings senior clinical, statistical, regulatory, medical, and operational experts together around your program, providing the scientific depth and cross-functional perspective needed to navigate difficult decisions.

team-01

Amil Evara

Partner
team-04

Nat Reynolds

Partner
team-03

Suzan Lois

Graphic Designer
team-09

James Oliver

Associate Partner
x
team-01

Amil Evara

Partner
61, Alexandria USA
Egestas congue quisque egestas diam in. Venenatis cras sed felis eget velit aliquet sagittis. In egestas erat imperdiet sed. Viverra maecenas accumsan lacus vel facilisis volutpat est velit. Pretium lectus quam id leo in vitae turpis massa sed. Nibh sed pulvinar proin gravida hendrerit lectus. Semper viverra nam libero justo laoreet sit amet cursus.
x
team-04

Nat Reynolds

Partner
61108 Block Locks, North Otto
Volutpat commodo sed egestas egestas fringilla. Nisl rhoncus mattis rhoncus urna neque viverra justo nec. Feugiat in fermentum posuere urna. Morbi blandit cursus risus at ultrices mi. A diam sollicitudin tempor id eu nisl nunc. Vulputate odio ut enim blandit. Id volutpat lacus laoreet non curabitur gravida arcu ac tortor.
x
team-03

Suzan Lois

Graphic Designer
73421 O'Conner Divide, Cortezmouth
Arcu odio ut sem nulla. Aliquet eget sit amet tellus cras adipiscing enim eu turpis. Tellus cras adipiscing enim eu turpis egestas. Quisque sagittis purus sit amet volutpat consequat mauris. Mauris ultrices eros in cursus turpis massa. Pharetra vel turpis nunc eget. Rhoncus est pellentesque elit ullamcorper dignissim cras tincidunt lobortis feugiat.
x
team-09

James Oliver

Associate Partner
Apt. 843 32344 Schumm Union, Domenicland
Diam donec adipiscing tristique risus nec feugiat. Enim eu turpis egestas pretium aenean pharetra. Porttitor leo a diam sollicitudin tempor id eu nisl. Faucibus in ornare quam viverra orci. Semper risus in hendrerit gravida rutrum quisque. Blandit libero volutpat sed cras. Adipiscing diam donec adipiscing tristique risus nec.
PROOF & RESOURCES
Perspectives on Complex Clinical Development

 

Explore perspectives from Veristat experts on clinical trial design and execution, regulatory strategy, biometrics, rare disease, oncology, cell and gene therapy, and other challenges shaping Phase I–IV development.

Bring the Right CRO to Your Next Phase

A protocol that’s hard to execute. An endpoint that doesn’t hold up. A regulatory requirement discovered too late. In complex development, the cost of the wrong decision rarely stays contained to a single study.

Whether you are preparing for a first-in-human study, making a critical Phase II decision, planning a pivotal Phase III trial, or building toward submission, bring Veristat into the conversation.

Frequently Asked Questions